高级检索
当前位置: 首页 > 详情页

Treatment of renal calculi without hydronephrosis using a standard channel assisted by a visual puncture system

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Hebei Univ, Coll Med, Baoding, Hebei, Peoples R China [2]Hebei Univ, Dept Urol, Affiliated Hosp, Baoding 071030, Hebei, Peoples R China [3]Unit 66069 79 PLA, Luoyang, Henan, Peoples R China
出处:
ISSN:

关键词: Visual puncture system percutaneous nephrolithotomy renal calculi without hydronephrosis hemorrhage standard channel duration of surgery

摘要:
Objective: To study the safety and efficacy of standard channel establishment using a visual puncture system in the treatment of renal calculi without hydronephrosis. Methods: We retrospectively analyzed data from 46 patients undergoing percutaneous nephrolithotomy via a standard channel assisted by a visual puncture system, including number of punctures, duration of procedure, hemoglobin level after surgery, calculi clearance rate, and postoperative complications. Results: Sixty-nine channels were established, including a single channel in 26 cases, double channel in 17 cases, and three channels in 3 cases. The mean number of punctures was 1.50, mean time to establish the standard channel was 2.6 minutes, and duration of surgery was 31.3 minutes. No significant change in hemoglobin was observed after surgery. Forty-three patients had no residual calculi and three had small residual calculi on the day after surgery, representing a first-phase clearance rate of 93.48% (43/46). No significant complications were observed. Conclusions: Hemorrhage during operation can be significantly reduced by establishing a standard channel using a visual puncture system. Moreover, the number of standard channels can be reduced and the incidence of complications lowered using this approach, which should be adopted widely for the treatment of renal calculi without hydronephrosis.

语种:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2021]版:
大类 | 4 区 医学
小类 | 4 区 医学:研究与实验 4 区 药学
最新[2025]版:
大类 | 4 区 医学
小类 | 4 区 医学:研究与实验 4 区 药学
JCR分区:
出版当年[2020]版:
Q4 PHARMACOLOGY & PHARMACY Q4 MEDICINE, RESEARCH & EXPERIMENTAL
最新[2023]版:
Q4 MEDICINE, RESEARCH & EXPERIMENTAL Q4 PHARMACOLOGY & PHARMACY

影响因子: 最新[2023版] 最新五年平均 出版当年[2020版] 出版当年五年平均 出版前一年[2019版] 出版后一年[2021版]

第一作者:
第一作者机构: [1]Hebei Univ, Coll Med, Baoding, Hebei, Peoples R China
通讯作者:
通讯机构: [2]Hebei Univ, Dept Urol, Affiliated Hosp, Baoding 071030, Hebei, Peoples R China [*1]Department of Urology, Affiliated Hospital of Hebei University, Baoding, Hebei, 071030, P. R. China. [*2]Department of Urology, Affiliated Hospital of Hebei University.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:15101 今日访问量:3 总访问量:963 更新日期:2025-05-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 河北大学附属医院 技术支持:重庆聚合科技有限公司 地址:保定市莲池区裕华东路212号